In silico experimentation of glioma microenvironment development and anti-tumor therapy

PLoS Computational Biology

Volumn 8, Issue 2, 2012, Pages

  Wu, Yu ^a   Lu, Yao ^a   Chen, Weiqiang ^b   Fu, Jianping ^b   Fan, Rong ^a,c,d  

^a Yale University   (United States)

^b UNIVERSITY OF MICHIGAN   (United States)

^c YALE UNIVERSITY   (United States)

^d YALE CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELL SIGNALING; CELLS; CYTOLOGY; PATIENT MONITORING; SIGNALING;

ANTI-TUMORS; CYTOKINES; IN-SILICO; INTERCELLULAR SIGNALLING; MICROENVIRONMENTS; MICROGLIA; SIGNALING NETWORKS; TUMOR MICROENVIRONMENTS; TUMOR THERAPY; TUMOUR CELLS;

TUMORS;

ARTICLE; ASTROCYTE; CANCER STEM CELL; CANCER THERAPY; CARCINOGENESIS; CELL COMMUNICATION; COMPUTER MODEL; GLIOBLASTOMA; INTRACELLULAR SIGNALING; MICROGLIA; MOLECULARLY TARGETED THERAPY; PROTEIN INTERACTION; TUMOR MICROENVIRONMENT; BIOLOGICAL MODEL; COMPUTER SIMULATION; GLIOMA; HUMAN; METABOLISM; PATHOLOGY; SIGNAL TRANSDUCTION;

ANTINEOPLASTIC AGENT; CYTOKINE;

ANTINEOPLASTIC AGENTS; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; ASTROCYTES; COMPUTER SIMULATION; CYTOKINES; GLIOMA; HUMANS; MICROGLIA; MODELS, BIOLOGICAL; SIGNAL TRANSDUCTION; TUMOR MICROENVIRONMENT;

EID: 84861134237     PISSN: 1553734X     EISSN: 15537358     Source Type: Journal    
DOI: 10.1371/journal.pcbi.1002355     Document Type: Article

References (63)

1. Hanahan D, Weinberg RA, (2011) Hallmarks of Cancer: The Next Generation. Cell 144: 646-674.
2. Weinberg RA, (2008) Coevolution in the tumor microenvironment. Nat Genet 40: 494-495.
3. Anderson ARA, Weaver AM, Cummings PT, Quaranta V, (2006) Tumor morphology and phenotypic evolution driven by selective pressure from the microenvironment. Cell 127: 905-915.
4. Tlsty TD, Coussens LM, (2006) Tumor stroma and regulation of cancer development. Annu Rev Pathol-Mech 1: 119-150.
5. Polyak K, Haviv I, Campbell IG, (2009) Co-evolution of tumor cells and their microenvironment. Trends Genet 25: 30-38.
6. Sawyers CL, (2007) Where lies the blame for resistance- tumor or host? Nat Med 13: 1144-1145.
7. Karlou M, Tzelepi V, Efstathiou E, (2010) Therapeutic targeting of the prostate cancer microenvironment. Nat Rev Urol 7: 494-509.
8. Joyce JA, (2005) Therapeutic targeting of the tumor microenvironment. Cancer Cell 7: 513-520.
9. Hu M, Polyak K, (2008) Microenvironmental regulation of cancer development. Curr Opin Genet Dev 18: 27-34.
10. Das S, Srikanth M, Kessler JA, (2008) Cancer stem cells and glioma. Nat Clin Pract Neuro 4: 427-435.
11. Furnari FB, Fenton T, Bachoo RM, Mukasa A, Stommel JM, et al. (2007) Malignant astrocytic glioma: genetics, biology, and paths to treatment. Gene Dev 21: 2683-2710.
12. Iwasa Y, Michor F, (2011) Evolutionary Dynamics of Intratumor Heterogeneity. PLoS One 6: e17866.
13. Clarke MF, Dick JE, Dirks PB, Eaves CJ, Jamieson CHM, et al. (2006) Cancer stem cells-perspectives on current status and future directions: AACR Workshop on cancer stem cells. Cancer Res 66: 9339-9344.
14. Bao SD, Wu QL, Sathornsumetee S, Hao YL, Li ZZ, et al. (2006) Stem cell-like glioma cells promote tumor angiogenesis through vascular endothelial growth factor. Cancer Res 66: 7843-7848.
15. Singh SK, Hawkins C, Clarke ID, Squire JA, Bayani J, et al. (2004) Identification of human brain tumour initiating cells. Nature 432: 396-401.
16. Beier D, Hau P, Proescholdt M, Lohmeier A, Wischhusen J, et al. (2007) CD133(+) and CD133(-) glioblastoma-derived cancer stem cells show differential growth characteristics and molecular profiles. Cancer Res 67: 4010-4015.
17. Joo KM, Kim SY, Jin X, Song SY, Kong DS, et al. (2008) Clinical and biological implications of CD133-positive and CD133-negative cells in glioblastomas. Lab Invest 88: 808-815.
18. Ogden AT, Waziri AE, Lochhead RA, Fusco D, Lopez K, et al. (2008) Identification of A2B5(+)CD133-tumor-initiating cells in adult human gliomas. Neurosurgery 62: 505-514.
19. Wang J, Sakariassen PO, Tsinkalovsky O, Immervoll H, Boe SO, et al. (2008) CD133 negative glioma cells form tumors in nude rats and give rise to CD133 positive cells. Int J Cancer 122: 761-768.
20. Roggendorf W, Strupp S, Paulus W, (1996) Distribution and characterization of microglia/macrophages in human brain tumors. Acta Neuropathol 92: 288-293.
21. Leung SY, Wong MP, Chung LP, Chan ASY, Yuen ST, (1997) Monocyte chemoattractant protein-1 expression and macrophage infiltration in gliomas. Acta Neuropathol 93: 518-527.
22. Prat E, Baron P, Meda L, Scarpini E, Galimberti D, et al. (2000) The human astrocytoma cell line U373MG produces monocyte chemotactic protein (MCP)-1 upon stimulation with beta-amyloid protein. Neurosci Lett 283: 177-180.
23. Platten M, Kretz A, Naumann U, Aulwurm S, Egashira K, et al. (2003) Monocyte chemoattractant protein-1 increases microglial infiltration and aggressiveness of gliomas. Ann Neurol 54: 388-392.
24. Galasso JM, Stegman LD, Blaivas M, Harrison JK, Ross BD, et al. (2000) Experimental gliosarcoma induces chemokine receptor expression in rat brain. Exp Neurol 161: 85-95.
25. Huettner C, Czub S, Kerkau S, Roggendorf W, Tonn JC, (1997) Interleukin 10 is expressed in human gliomas in vivo and increases glioma cell proliferation and motility in vitro. Anticancer Res 17: 3217-3224.
26. Badie B, Schartner J, (2001) Role of microglia in glioma biology. Microsc Res Techniq 54: 106-113.
27. Bettinger I, Thanos S, Paulus W, (2002) Microglia promote glioma migration. Acta Neuropathol 103: 351-355.
28. Giulian D, Baker TJ, (1986) Characterization of ameboid microglia isolated from developing mammalian brain. J Neurosci 6: 2163-2178.
29. Fontana A, Kristensen F, Dubs R, Gemsa D, Weber E, (1982) Production of prostaglandin-e and an interleukin-1 like factor by cultured astrocytes and c6 glioma-cells. J Immunol 129: 2413-2419.
30. Paugh BS, Bryan L, Paugh SW, Wilczynska KM, Alvarez SM, et al. (2009) Interleukin-1 Regulates the Expression of Sphingosine Kinase 1 in Glioblastoma Cells. J Biol Chem 284: 3408-3417.
31. Tada M, Detribolet N, (1993) Recent advances in immunobiology of brain-tumors. J Neuro-Oncol 17: 261-271.
32. Yamanaka R, Tanaka R, Saitoh T, Okoshi S, (1994) Cytokine gene-expression on glioma cell-lines and specimens. J Neuro-Oncol 21: 243-247.
33. Sunderkotter C, Steinbrink K, Goebeler M, Bhardwaj R, Sorg C, (1994) Macrophages and angiogenesis. J Leukocyte Biol 55: 410-422.
34. Saijo Y, Tanaka M, Miki M, Usui K, Suzuki T, et al. (2002) Proinflammatory cytokine IL-1 beta promotes tumor growth of Lewis lung carcinoma by induction of angiogenic factors: In vivo analysis of tumor-stromal interaction. J Immunol 169: 469-475.
35. Voronov E, Shouval DS, Krelin Y, Cagnano E, Benharroch D, et al. (2003) IL-1 is required for tumor invasiveness and angiogenesis. Proc Natl Acad Sci USA 100: 2645-2650.
36. Chung IY, Benveniste EN, (1990) Tumor necrosis factor-alpha production by astrocytes- induction by lipopolysaccharide, IFN-gamma, and IL-1-beta. J Immunol 144: 2999-3007.
37. Su ZD, Yuan YM, Chen JJ, Cao L, Zhu YL, et al. (2009) Reactive Astrocytes in Glial Scar Attract Olfactory Ensheathing Cells Migration by Secreted TNF-alpha in Spinal Cord Lesion of Rat. PLoS One 4: e8141.
38. Van Wagoner NJ, Oh JW, Repovic P, Benveniste EN, (1999) Interleukin-6 (IL-6) production by astrocytes: Autocrine regulation by IL-6 and the soluble IL-6 receptor. J Neurosci 19: 5236-5244.
39. Ryuto M, Ono M, Izumi H, Yoshida S, Weich HA, et al. (1996) Induction of vascular endothelial growth factor by tumor necrosis factor alpha in human glioma cells- Possible roles of SP-1. J Biol Chem 271: 28220-28228.
40. Adachi K, Belser P, Bender H, Li DR, Rodeck U, et al. (1992) Enhancement of epidermal growth-factor receptor expression on glioma-cells by recombinant tumor-necrosis-factor-alpha. Cancer Immunol Immun 34: 370-376.
41. Esteve PO, Chicoine E, Robledo O, Aoudjit F, Descoteaux A, et al. (2002) Protein kinase C-zeta regulates transcription of the matrix metalloproteinase-9 gene induced by IL-1 and TNF-alpha in glioma cells via NF-kappa B. J Biol Chem 277: 35150-35155.
42. Quaranta V, Rejniak KA, Gerlee P, Anderson ARA, (2008) Invasion emerges from cancer cell adaptation to competitive microenvironments: Quantitative predictions from multiscale mathematical models. Semin Cancer Biol 18: 338-348.
43. Lucas B, Edelman JAE, Nathan DPrice, (2010) In silico models of cancer. Wiley Interdiscip Rev-Syst Biol 2: 438-459.
44. Watters JJ, Schartner JM, Badie B, (2005) Microglia function in brain tumors. J Neurosci Res 81: 447-455.
45. Graeber MB, Scheithauer BW, Kreutzberg GW, (2002) Microglia in brain tumors. Glia 40: 252-259.
46. Fan XL, Salford LG, Widegren B, (2007) Glioma stem cells: Evidence and limitation. Semin Cancer Biol 17: 214-218.
47. Holland EC, Hively WP, DePinho RA, Varmus HE, (1998) A constitutively active epidermal growth factor receptor cooperates with disruption of G(1) cell-cycle arrest pathways to induce glioma-like lesions in mice. Gene Dev 12: 3675-3685.
48. Jellinger K, (1978) Glioblastoma multiforme- morphology and biology. Acta Neurochir 42: 5-32.
49. Hatten ME, (1985) Neuronal regulation of astroglial morphology and proliferation invitro. J Cell Biol 100: 384-396.
50. Schreiber H, Rowley DA, (2010) Awakening Immunity. Science 330: 761-762.
51. Xie Q, Thompson R, Hardy K, DeCamp L, Berghuis B, et al. (2008) A highly invasive human glioblastoma pre-clinical model for testing therapeutics. J Transl Med 6: 77.
52. Stoker MGP, Rubin H, (1967) Density dependent inhibition of cell growth in culture. Nature 215: 171-&.
53. Lopes MBS, Vandenberg SR, Scheithauer BW, (1995) Histopathology, immunochemistry and ultrastructure of brain tumors. In: Kaye AH, Laws ER, editors. Brain tumors: An encyclopedic approach Edinburgh Churchill Livingstone pp. 125-162.
54. McKnight TR, Lamborn KR, Love TD, Berger MS, Chang S, et al. (2007) Correlation of magnetic resonance spectroscopic and growth characteristics within Grades II and III gliomas. J Neurosurg 106: 660-666.
55. Marumoto T, Tashiro A, Friedmann-Morvinski D, Scadeng M, Soda Y, et al. (2009) Development of a novel mouse glioma model using lentiviral vectors. Nat Med 15: 110-116.
56. Lee SC, Liu W, Dickson DW, Brosnan CF, Berman JW, (1993) Cytokine production by human fetal microglia and astrocytes- differential induction by lipopolysaccharide and IL-1-beta. J Immunol 150: 2659-2667.
57. Wu M, Pastor-Pareja JC, Xu T, (2010) Interaction between Ras(V12) and scribbled clones induces tumour growth and invasion. Nature 463: 545-U165.
58. Takano S, Yoshii Y, Kondo S, Suzuki H, Maruno T, et al. (1996) Concentration of vascular endothelial growth factor in the serum and tumor tissue of brain tumor patients. Cancer Res 56: 2185-2190.
59. Irish JM, Kotecha N, Nolan GP, (2006) Innovation- Mapping normal and cancer cell signalling networks: towards single-cell proteomics. Nat Rev Cancer 6: 146-155.
60. Xu B, Du W, Liu BF, Luo QM, (2006) Single cell proteomics: Challenge for current analytical science. Curr Anal Chem 2: 67-76.
61. Huang B, Wu HK, Bhaya D, Grossman A, Granier S, et al. (2007) Counting low-copy number proteins in a single cell. Science 315: 81-84.
62. Kotecha N, Floress NJ, Irish JM, Simonds EF, Sakai DS, et al. (2008) Single-cell profiling identifies aberrant STAT5 activation in myeloid malignancies with specific clinical and biologic correlates. Cancer Cell 14: 335-343.
63. Ma C, Fan R, Ahmad H, Shi Q, Comin-Anduix B, et al. (2011) A clinical microchip for evaluation of single immune cells reveals high functional heterogeneity in phenotypically similar T cells. Nat Med 17: 738-U133.